NASDAQ:AHCO - Nasdaq - US00653Q1022 - Common Stock
ADAPTHEALTH CORP
NASDAQ:AHCO (1/21/2025, 8:00:00 PM)
After market: 10.5 0 (0%)10.5
-0.02 (-0.19%)
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -4.92% | ||
ROE | -14.49% | ||
Debt/Equity | 1.35 |
AdaptHealth Corp. engages in the provision of home healthcare equipment, supplies and related services. The company is headquartered in Plymouth Meeting, Pennsylvania and currently employs 10,700 full-time employees. The company went IPO on 2018-02-21. The firm is primarily focused on providing sleep therapy equipment, supplies and related services, including CPAP and bi PAP services to individuals suffering from obstructive sleep apnea (OSA); medical devices and supplies to patients for the treatment of diabetes, including continuous glucose monitors (CGM) and insulin pumps; home medical equipment to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. The firm services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company serves patients annually in all 50 states through its network of approximately 680 locations in 47 states.
ADAPTHEALTH CORP
220 W Germantown Pike Ste 250
Plymouth Meeting PENNSYLVANIA 19462 US
CEO: Luke McGee
Employees: 10700
Company Website: https://adapthealth.com/investor-relations/
Investor Relations: https://adapthealth.com/investorrelations/
Phone: 16106306357
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MCK | MCKESSON CORP | 20.3 | 74.40B | ||
COR | CENCORA INC | 17.81 | 47.37B | ||
CAH | CARDINAL HEALTH INC | 16.78 | 30.94B | ||
HSIC | HENRY SCHEIN INC | 17.62 | 9.25B | ||
PDCO | PATTERSON COS INC | 14.6 | 2.73B | ||
OMI | OWENS & MINOR INC | 8.99 | 1.15B | ||
AHG | AKSO HEALTH GROUP | N/A | 594.24M | ||
COSM | COSMOS HEALTH INC | N/A | 21.63M | ||
VRAX | VIRAX BIOLABS GROUP LTD | N/A | 9.07M | ||
ATPC | AGAPE ATP CORP | N/A | 5.99M |